Cite
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting
MLA
Silvia Pomella, et al. “MYOD-SKP2 Axis Boosts Tumorigenesis in Fusion Negative Rhabdomyosarcoma by Preventing Differentiation through P57Kip2 Targeting.” Nature Communications, vol. 14, no. 1, Dec. 2023, pp. 1–23. EBSCOhost, https://doi.org/10.1038/s41467-023-44130-0.
APA
Silvia Pomella, Matteo Cassandri, Lucrezia D’Archivio, Antonella Porrazzo, Cristina Cossetti, Doris Phelps, Clara Perrone, Michele Pezzella, Antonella Cardinale, Marco Wachtel, Sara Aloisi, David Milewski, Marta Colletti, Prethish Sreenivas, Zoë S. Walters, Giovanni Barillari, Angela Di Giannatale, Giuseppe Maria Milano, Cristiano De Stefanis, … Rossella Rota. (2023). MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting. Nature Communications, 14(1), 1–23. https://doi.org/10.1038/s41467-023-44130-0
Chicago
Silvia Pomella, Matteo Cassandri, Lucrezia D’Archivio, Antonella Porrazzo, Cristina Cossetti, Doris Phelps, Clara Perrone, et al. 2023. “MYOD-SKP2 Axis Boosts Tumorigenesis in Fusion Negative Rhabdomyosarcoma by Preventing Differentiation through P57Kip2 Targeting.” Nature Communications 14 (1): 1–23. doi:10.1038/s41467-023-44130-0.